Phase 2 Breast Cancer Trial, Recruiting NCT07007169 Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Recruiting

NCT07007169
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have given written consent that has been approved by an ethics review board
  • People aged 18 or older
  • People who have been diagnosed through a tissue sample (biopsy) with breast cancer affecting one breast only, classified as stage I, II, or III, and who are planned to receive chemotherapy either before or after surgery aimed at removing the cancer, following Danish breast cancer treatment guidelines — this includes cases where additional targeted treatments (for certain tumour types) are also being given alongside chemotherapy
  • People who are in generally good health and able to carry out daily activities with no or minimal limitations (confirm with trial site)
  • People who are willing to follow the treatment and study-related procedures as set out in the trial plan
  • People who have access to a smartphone or computer that can receive emails, for use with an online food diary
  • People who are willing to avoid probiotic supplements (products containing live bacteria or microorganisms) for the duration of the study — fermented foods such as yoghurt are still permitted

Who may not be able to join:

  • People who have signs — either from physical examination or scans — that the cancer has spread to other parts of the body
  • People who have had another cancer diagnosed within the past five years, except for certain early-stage cervical changes (carcinoma in situ) or common non-melanoma skin cancers
  • People who have previously received chemotherapy for any cancer or other serious disease
  • People who have significant conditions affecting how their digestive system works, such as gastric bypass surgery, Crohn's disease, or ulcerative colitis
  • People who are not able to communicate effectively in Danish or English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +45 2053 3235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Registry
ClinicalTrials.gov
Start date
27 March 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in microbiota composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov